CST3 and type 2 diabetes mellitus: For people with T2DM at the time of enrolment (w T2DM), Cystatin C was particularly important to predict all 6 CVD outcomes, with a feature importance of 0.028 for CHD in the “w T2DM” group, compared to only 0.001 in people without diabetes.